unknown
Stage
About
GlucoModicum develops non-invasive, needle-free biosensing technology for monitoring glucose and other biomarkers. Its proprietary magnetohydrodynamic (MHD) platform powers wearable glucose monitors such as its single-day Sofio device.
Explore GlucoModicum's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.